OR WAIT null SECS
December 01, 2022
According to the authors, a patient with bilateral choroid metastases from breast cancer experienced "a dramatic response" after a combination treatment of abemaciclib and fulvestrant.
November 30, 2022
Jacqueline Theis, OD, FAAO, gives key takeaways from her discussion on treating photophobia in patients, which she presented during the 2022 American Academy of Optometry meeting.
November 29, 2022
As technology advances and choices grow, you need to personalize patients’ options.
November 24, 2022
Case history can give clues to a patient’s risk of developing diabetic eye disease.
November 23, 2022
Chris Kenrick, OD, shares what she finds to be most important from her discussion this year at AAOpt 2022.
November 22, 2022
Modern technology enables early detection, individualized solutions.
November 16, 2022
Jessica Steen, OD, FAAO, gave an ophthalmic therapeutic update during the 2022 American Academy of Optometry Meeting.
November 15, 2022
Brad Sutton, OD, FAAO, FORS, discusses key takeaways from his discussion, "Genetic testing in AMD: critical, useful, or inappropriate," which he presented during the 2022 American Academy of Optometry meeting.
Increasing scleral lens use can benefit a larger patient base.
November 14, 2022
Combining products and resources in creative ways can help grow your business.
Case report: Combination treatment proves effective for choroidal metastasis from breast cancer patient
Alcon completes acquisition of Aerie Pharmaceuticals
Words matter: Update how you talk to your patients
FDA approves intravenous injection for delayed onset of stage 3 type 1 diabetes
